Key facts
- It has raised $330K; the latest was Early Stage VC in Jul 2025.
- Notable investors include StartLife, Delft Enterprises, Innovatiefonds Noord-Holland, Regenerative (Swiss), Philips Innovation Award — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Respyre
- ·The full record, as it builds
Funding rounds
No funding rounds for Respyre are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Respyre
Developer of a bioreceptive facade system designed to integrate moss growth into urban infrastructure for environmental and public health benefits. The company's system offers a sustainable concrete cladding combined with a nutrient-rich moss gel, enabling architects, urban developers and municipalities to create self-sustaining green surfaces that improve air quality, reduce heat, absorb water and promote biodiversity.
- Sector
- Materials and Resources
- HQ
- Leiden, Netherlands
- Founded
- 2021
- Employees
- 6
- Website
- gorespyre.com/
- Ownership
- Privately Held (backing)
Respyre doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Respyre shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Respyre in its N-PORT filings yet. We sweep new filings monthly.